Related Experiment Video

Updated: Oct 16, 2025

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.5K

Call to action: cardiologists should promote influenza vaccination

G L Habib1, H Yousuf1, J Narula2

  • 1Department of Cardiology, Amsterdam University Medical Centres, location VU University medical center, Amsterdam, The Netherlands.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|October 14, 2021
PubMed

Insights

Cardiologists should promote seasonal influenza vaccination. Studies show influenza significantly increases heart attack risk, and the flu vaccine is effective in preventing these cardiovascular complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 highlights the vulnerability of patients with cardiac conditions.
  • Influenza is a known risk factor for cardiovascular complications, including acute myocardial infarction.
  • Seasonal influenza vaccination is crucial for protecting high-risk cardiac patients.

Purpose of the Study:

  • To emphasize the importance of influenza vaccination for patients with cardiovascular disease.
  • To review the association between influenza and acute myocardial infarction.
  • To advocate for cardiologists to promote seasonal flu vaccination.

Main Methods:

  • Literature review on influenza and cardiovascular complications.
  • Analysis of studies reporting the risk of acute myocardial infarction after influenza infection.
  • Comparison of influenza vaccine effectiveness with secondary preventive therapies for cardiovascular disease.

Main Results:

  • Laboratory-confirmed influenza is associated with a 6.05-8.89 times higher risk of hospital admission for acute myocardial infarction within 7 days.
  • Influenza vaccination demonstrates approximately 29% effectiveness in preventing acute myocardial infarction.
  • This effectiveness is comparable to or exceeds that of statins, antihypertensives, and smoking cessation.

Conclusions:

  • Influenza vaccination is a vital preventive measure for patients with cardiovascular disease.
  • Cardiologists play a key role in promoting seasonal influenza vaccination among their patients.
  • Promoting flu shots can significantly reduce the incidence of cardiovascular complications.

Keywords:
COVID-19Cardiovascular DiseasesGlobal Burden of DiseaseHumanInfluenzaVaccines

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.3K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.9K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
396
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
48
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
65
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
114
Vaccinations01:51

Vaccinations

Overview
46.3K